{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:08:48Z","timestamp":1773112128846,"version":"3.50.1"},"reference-count":181,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.autrev.2017.05.016","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T07:17:13Z","timestamp":1496128633000},"page":"845-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Survivin in autoimmune diseases"],"prefix":"10.1016","volume":"16","author":[{"given":"G.","family":"Gravina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Was\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Garcia-Bonete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Turkkila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Erlandsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"T\u00f6yr\u00e4 Silfversw\u00e4rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Brisslert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pullerits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Katona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.I.","family":"Bokarewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.05.016_bb0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-4598-4-11","article-title":"Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies","volume":"4","author":"Caldas","year":"2005","journal-title":"Mol Cancer"},{"key":"10.1016\/j.autrev.2017.05.016_bb0015","first-page":"6097","article-title":"Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties","volume":"59","author":"Mahotka","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0020","doi-asserted-by":"crossref","first-page":"27204","DOI":"10.1074\/jbc.M705161200","article-title":"Forced expression of survivin-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivin","volume":"282","author":"Ling","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.016_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.34","article-title":"Survivin-2B promotes autophagy by accumulating IKK alpha in the nucleus of selenite-treated NB4 cells","volume":"5","author":"Shi","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.autrev.2017.05.016_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2006.12.020","article-title":"Survivin: a promising tumor biomarker","volume":"249","author":"Duffy","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.autrev.2017.05.016_bb0035","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/sj.cdd.4401091","article-title":"Differential subcellular localization of functionally divergent survivin splice variants","volume":"9","author":"Mahotka","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2017.05.016_bb0040","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrm3474","article-title":"The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis","volume":"13","author":"Carmena","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0045","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1091\/mbc.e11-11-0904","article-title":"Molecular basis for phosphospecific recognition of histone H3 tails by Survivin paralogues at inner centromeres","volume":"23","author":"Niedzialkowska","year":"2012","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.autrev.2017.05.016_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20100814","article-title":"Survivin and IAP proteins in cell-death mechanisms","volume":"430","author":"Altieri","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2017.05.016_bb0055","doi-asserted-by":"crossref","first-page":"26202","DOI":"10.1074\/jbc.M700776200","article-title":"Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex","volume":"282","author":"Arora","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.016_bb0060","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbrc.2016.11.094","article-title":"Survivin does not influence the anti-apoptotic action of XIAP on caspase-9","volume":"482","author":"Zumbragel","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2017.05.016_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(00)00008-8","article-title":"Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition","volume":"102","author":"Du","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.05.016_bb0070","first-page":"663","article-title":"Survivin controls biogenesis of microRNA in smokers: a link to pathogenesis of rheumatoid arthritis","volume":"2017","author":"Andersson","year":"1863","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2017.05.016_bb0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/cc.1.5.149","article-title":"Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry","volume":"1","author":"Fukuda","year":"2002","journal-title":"Cell Cycle"},{"key":"10.1016\/j.autrev.2017.05.016_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/blood-2003-05-1756","article-title":"Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1\/Cip1-dependent and -independent pathways","volume":"103","author":"Fukuda","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.05.016_bb0085","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1182\/blood.V98.7.2091","article-title":"Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis","volume":"98","author":"Fukuda","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.05.016_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.20032092","article-title":"Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death","volume":"199","author":"Okada","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20031588","article-title":"Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis","volume":"199","author":"Xing","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0100","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20032033","article-title":"Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils","volume":"199","author":"Altznauer","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0105","first-page":"428","article-title":"Two-stage maxillary ridge augmentation using durapatite","volume":"13","author":"Koslen","year":"1987","journal-title":"J Oral Implantol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0110","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0002-9440(10)64131-4","article-title":"Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting","volume":"158","author":"Mesri","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0115","doi-asserted-by":"crossref","first-page":"11480","DOI":"10.1073\/pnas.0500303102","article-title":"Differential requirements for survivin in hematopoietic cell development","volume":"102","author":"Gurbuxani","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.016_bb0120","doi-asserted-by":"crossref","first-page":"946936","DOI":"10.1155\/2011\/946936","article-title":"Survivin selectively modulates genes deregulated in human leukemia stem cells","volume":"2011","author":"Fukuda","year":"2011","journal-title":"J Oncol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0125","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1084\/jem.20062395","article-title":"Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells","volume":"204","author":"Leung","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/leu.2014.183","article-title":"Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1","volume":"29","author":"Fukuda","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.autrev.2017.05.016_bb0135","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.V100.7.2463","article-title":"The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells","volume":"100","author":"Fukuda","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.05.016_bb0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.scr.2014.01.002","article-title":"Differential localization and high expression of SURVIVIN splice variants in human embryonic stem cells but not in differentiated cells implicate a role for SURVIVIN in pluripotency","volume":"12","author":"Mull","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jcp.24681","article-title":"microRNA-mediated survivin control of pluripotency","volume":"230","author":"Kapinas","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/cmi.2008.30","article-title":"Intracellular signals of T cell costimulation","volume":"5","author":"Song","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0155","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/eji.201243081","article-title":"Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation","volume":"43","author":"Lei","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00186-9","article-title":"Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells","volume":"76","author":"Kornacker","year":"2001","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2017.05.016_bb0165","doi-asserted-by":"crossref","first-page":"20043","DOI":"10.18632\/oncotarget.4994","article-title":"Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6","volume":"6","author":"Andersson","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2017.05.016_bb0170","doi-asserted-by":"crossref","first-page":"15478","DOI":"10.1073\/pnas.0703725104","article-title":"Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40","volume":"104","author":"Niedbala","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.016_bb0175","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.1501690","article-title":"Essential role for survivin in the proliferative expansion of progenitor and mature B cells","volume":"196","author":"Miletic","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102231","article-title":"Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study","volume":"9","author":"Kusner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.016_bb0185","doi-asserted-by":"crossref","first-page":"R349","DOI":"10.1186\/ar1498","article-title":"Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis","volume":"7","author":"Bokarewa","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.016_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/07853890903376280","article-title":"Increased expression of proto-oncogene survivin predicts joint destruction and persistent disease activity in early rheumatoid arthritis","volume":"42","author":"Svensson","year":"2010","journal-title":"Ann Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13075-015-0689-z","article-title":"Suppressed diversity of survivin splicing in active rheumatoid arthritis","volume":"17","author":"Turkkila","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.016_bb0200","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/cmi.2016.58","article-title":"Cellular and molecular regulation of innate inflammatory responses","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0205","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nm1474","article-title":"LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia","volume":"12","author":"Skokowa","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1189\/jlb.0507282","article-title":"Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin","volume":"83","author":"Hu","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-017-1141-8","article-title":"Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity","volume":"15","author":"Navegantes","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0220","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood-2011-03-342428","article-title":"Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells","volume":"119","author":"Singh","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.05.016_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047668","article-title":"Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis","volume":"7","author":"Andersson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.016_bb0230","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1136\/ard.2005.040477","article-title":"Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis","volume":"64","author":"van Holten","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.016_bb0235","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism","volume":"52","author":"Bave","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.016_bb0240","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1007\/s00018-015-2005-0","article-title":"Human dendritic cell subsets and function in health and disease","volume":"72","author":"O'Keeffe","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2017.05.016_bb0245","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/mmr.2015.3579","article-title":"Optimized generation of survivin-specific cytotoxic T lymphocytes against lung cancer","volume":"12","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2017.05.016_bb0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-015-0785-0","article-title":"CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis","volume":"17","author":"Mokuda","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.016_bb0255","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4236\/abb.2012.326085","article-title":"Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts","volume":"3","author":"Sisson","year":"2012","journal-title":"Adv Biosci Biotechnol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0260","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/labinvest.2013.103","article-title":"Role of survivin in acute lung injury: epithelial cells of mice and humans","volume":"93","author":"Terasaki","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2017.05.016_bb0265","first-page":"881","article-title":"Relationship of angiogenic factors to disease activity and radiographic damage in rheumatoid arthritis","volume":"26","author":"Park","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0270","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1111\/j.1582-4934.2009.00721.x","article-title":"Survivin is an essential mediator of arthritis interacting with urokinase signalling","volume":"13","author":"Baran","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0275","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar2603","article-title":"Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium","volume":"11","author":"Dharmapatni","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.016_bb0280","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1468-1331.2002.00454.x","article-title":"Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis","volume":"9","author":"Sharief","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0285","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/cbin.10331","article-title":"Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats","volume":"38","author":"Salem","year":"2014","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.autrev.2017.05.016_bb0290","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"Siddiquee","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.016_bb0295","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ijc.20954","article-title":"Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax","volume":"115","author":"Kawakami","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.autrev.2017.05.016_bb0300","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1158\/0008-5472.CAN-07-6673","article-title":"Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis","volume":"68","author":"Lee","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(03)13910-4","article-title":"Survivin and molecular pathogenesis of colorectal cancer","volume":"362","author":"Kim","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.05.016_bb0310","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1038\/sj.onc.1205353","article-title":"Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway","volume":"21","author":"Mirza","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.autrev.2017.05.016_bb0315","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1074\/jbc.M106643200","article-title":"Transcriptional repression of the anti-apoptotic survivin gene by wild type p53","volume":"277","author":"Hoffman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.016_bb0320","first-page":"8664","article-title":"Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer","volume":"61","author":"Zhang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0325","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1158\/0008-5472.CAN-09-0584","article-title":"Endogenous tumor suppression mediated by PTEN involves survivin gene silencing","volume":"69","author":"Guha","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0330","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/cbt.11.1.13730","article-title":"Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells","volume":"11","author":"Chen","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.autrev.2017.05.016_bb0335","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3892\/ijo.2014.2544","article-title":"KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1alpha","volume":"45","author":"Li","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0340","doi-asserted-by":"crossref","first-page":"L299","DOI":"10.1152\/ajplung.00189.2015","article-title":"KLF5 mediates vascular remodeling via HIF-1alpha in hypoxic pulmonary hypertension","volume":"310","author":"Li","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0345","article-title":"Inhibition of survivin reduces HIF-1alpha, TGF-beta1 and TFE3 in salivary adenoid cystic carcinoma","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.016_bb0350","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.7314\/APJCP.2014.15.19.8251","article-title":"Upregulation of HIF-1alpha by hypoxia protect neuroblastoma cells from apoptosis by promoting survivin expression","volume":"15","author":"Zhang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.autrev.2017.05.016_bb0355","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biocel.2011.10.011","article-title":"Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis","volume":"44","author":"Horowitz","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0360","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1183\/13993003.00773-2015","article-title":"Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension","volume":"48","author":"Dabral","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2017.05.016_bb0365","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1158\/0008-5472.CAN-06-3724","article-title":"Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis","volume":"67","author":"Sayeed","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0370","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: the fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.016_bb0375","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.taap.2009.10.020","article-title":"Nicotine-mediated signals modulate cell death and survival of T lymphocytes","volume":"242","author":"Oloris","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0380","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/carcin\/bgm234","article-title":"Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure","volume":"29","author":"Jin","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.autrev.2017.05.016_bb0385","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12032-010-9792-9","article-title":"Nicotine inhibits cisplatin-induced apoptosis in NCI-H446 cells","volume":"29","author":"Zeng","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0390","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jss.2011.12.029","article-title":"Nicotine stimulates proliferation and inhibits apoptosis in colon cancer cell lines through activation of survival pathways","volume":"178","author":"Cucina","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0395","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1073\/pnas.0509313103","article-title":"Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin","volume":"103","author":"Dasgupta","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.016_bb0400","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00795-013-0061-9","article-title":"Association of cigarette smoking with the expression of nuclear survivin in pathological stage IA lung adenocarcinomas","volume":"47","author":"Hirano","year":"2014","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0405","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4438","article-title":"Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study","volume":"16","author":"Svensson","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.016_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2016.12.009","article-title":"Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis","author":"Wasen","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.016_bb0415","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1352458517690270","article-title":"A systematic review of modifiable risk factors in the progression of multiple sclerosis","volume":"23","author":"Hempel","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2017.05.016_bb0420","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1331.2012.03843.x","article-title":"Smoking and socio-economic status may affect myasthenia gravis","volume":"20","author":"Maniaol","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0425","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1562\/0031-8655(2004)080<0602:URCAUO>2.0.CO;2","article-title":"Ultraviolet-B radiation causes an upregulation of survivin in human keratinocytes and mouse skin","volume":"80","author":"Aziz","year":"2004","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0430","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/156800907780809714","article-title":"Ultraviolet B regulation of transcription factor families: roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis","volume":"7","author":"Cooper","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.autrev.2017.05.016_bb0435","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0625.2008.00819.x","article-title":"Endogenous survivin modulates survival and proliferation in UVB-treated human keratinocytes","volume":"18","author":"Dallaglio","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0440","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2133.2010.10099.x","article-title":"Impact of etanercept treatment on ultraviolet B-induced inflammation, cell cycle regulation and DNA damage","volume":"164","author":"Gambichler","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0445","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0165-5728(01)00389-7","article-title":"Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis","volume":"119","author":"Sharief","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0450","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI23203","article-title":"Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension","volume":"115","author":"McMurtry","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.05.016_bb0455","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1365-2133.2006.07522.x","article-title":"Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy","volume":"155","author":"Markham","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0460","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2012.06.039","article-title":"Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease","volume":"143","author":"de Souza","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.05.016_bb0465","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0714.2008.00713.x","article-title":"Immunohistochemical analyses of survivin and heat shock protein 90 expression in patients with oral lichen planus","volume":"38","author":"Chaiyarit","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0470","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/rheumatology\/kep467","article-title":"Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment","volume":"49","author":"Smith","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.05.016_bb0475","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10753-010-9196-1","article-title":"Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: fibroblast-like synoviocytes as a potential source of extracellular survivin","volume":"33","author":"Ahn","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2017.05.016_bb0480","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/pgs.15.147","article-title":"Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients","volume":"17","author":"Jenko","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.autrev.2017.05.016_bb0485","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.semarthrit.2011.08.005","article-title":"High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis","volume":"41","author":"Isgren","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.016_bb0490","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12916-015-0485-2","article-title":"Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial","volume":"13","author":"Levitsky","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0495","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000468","article-title":"Recognizing rheumatoid arthritis: oncoprotein survivin opens new possibilities: a population-based case-control study","volume":"94","author":"Chun-Lai","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.05.016_bb0500","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar4474","article-title":"Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study","volume":"16","author":"Bokarewa","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.016_bb0505","first-page":"373","article-title":"Circulating survivin indicates severe course of juvenile idiopathic arthritis","volume":"26","author":"Galeotti","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0510","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1189\/jlb.3A0714-317R","article-title":"Down-regulation of survivin alleviates experimental arthritis","volume":"97","author":"Andersson","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0515","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1523\/JNEUROSCI.1446-05.2005","article-title":"Essential role for survivin in early brain development","volume":"25","author":"Jiang","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2017.05.016_bb0520","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2010.10.036","article-title":"Novel survivin mutant protects differentiated SK-N-SH human neuroblastoma cells from activated T-cell neurotoxicity","volume":"233","author":"Baratchi","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0525","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1523\/JNEUROSCI.1852-13.2013","article-title":"Survivin is a transcriptional target of STAT3 critical to estradiol neuroprotection in global ischemia","volume":"33","author":"Sehara","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2017.05.016_bb0530","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12035-015-9673-5","article-title":"Upregulating the expression of Survivin-HBXIP complex contributes to the protective role of IMM-H004 in transient global cerebral ischemia\/reperfusion","volume":"54","author":"Chu","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0535","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.3892\/mmr.2015.3857","article-title":"Neuroprotective effects of quercetin in a mouse model of brain ischemic\/reperfusion injury via anti-apoptotic mechanisms based on the Akt pathway","volume":"12","author":"Lei","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2017.05.016_bb0540","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00221-005-2362-2","article-title":"Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats","volume":"167","author":"Johnson","year":"2005","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0545","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.ajpath.2015.05.016","article-title":"Modulation of Sox10, HIF-1alpha, Survivin, and YAP by minocycline in the treatment of neurodevelopmental handicaps following hypoxic insult","volume":"185","author":"Li","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0550","first-page":"2787","article-title":"Nanoformulated mutant SurR9-C84A: a possible key for Alzheimer's and its associated inflammation","volume":"32","author":"Sriramoju","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0555","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4103\/1673-5374.194804","article-title":"Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response","volume":"11","author":"Koudriavtseva","year":"2016","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0560","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(05)60642-3","article-title":"Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis","volume":"351","author":"Pender","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.05.016_bb0565","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archneur.59.7.1115","article-title":"Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis","volume":"59","author":"Sharief","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0570","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.05.016_bb0575","first-page":"5","article-title":"Update on the pathogenesis of scleroderma: focus on circulating progenitor cells","author":"Brunasso","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0580","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3899\/jrheum.091087","article-title":"Autoantibody against survivin in patients with systemic sclerosis","volume":"37","author":"Koike","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0585","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS) cohort study","volume":"44","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.016_bb0590","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1183\/09059180.00007513","article-title":"Pathogenesis of pulmonary arterial hypertension: lessons from cancer","volume":"22","author":"Guignabert","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.autrev.2017.05.016_bb0595","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.112.103176","article-title":"Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid","volume":"126","author":"Zhao","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.05.016_bb0600","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.3892\/mmr.2016.4977","article-title":"Targeted inhibition of survivin with YM155 promotes apoptosis of hypoxic human pulmonary arterial smooth muscle cells via the upregulation of voltage-dependent K(+) channels","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2017.05.016_bb0605","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10641963.2014.987390","article-title":"YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channels","volume":"37","author":"Fan","year":"2015","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.autrev.2017.05.016_bb0610","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MAJ.0b013e31824cf5a2","article-title":"Increased expression of hypoxia-inducible factor-1alpha in proliferating neointimal lesions in a rat model of pulmonary arterial hypertension","volume":"345","author":"Yan","year":"2013","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autrev.2017.05.016_bb0615","doi-asserted-by":"crossref","first-page":"1356.e1","DOI":"10.1016\/j.cjca.2016.02.058","article-title":"Glycoprotein 130 inhibitor ameliorates monocrotaline-induced pulmonary hypertension in rats","volume":"32","author":"Huang","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0620","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/MIB.0000000000000660","article-title":"Stress in Crohn's disease and ulcerative colitis","volume":"22","author":"Cao","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2017.05.016_bb0625","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00129039-200106000-00007","article-title":"Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis","volume":"9","author":"Fogt","year":"2001","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0630","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1309\/YLX4L4H36K54X92H","article-title":"Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors. Association with survivin and bcl-2","volume":"119","author":"Mikami","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0635","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ibd.21178","article-title":"Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia","volume":"16","author":"Svec","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2017.05.016_bb0640","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/gtmb.2015.0036","article-title":"Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy","volume":"19","author":"Rapti","year":"2015","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.autrev.2017.05.016_bb0645","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ajpath.2016.03.008","article-title":"Epithelial PIK3R1 (p85) and TP53 regulate survivin expression during adaptation to ileocecal resection","volume":"186","author":"Cohran","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0650","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/cdd.2013.20","article-title":"Loss of survivin influences liver regeneration and is associated with impaired Aurora B function","volume":"20","author":"Hagemann","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2017.05.016_bb0655","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1021\/pr401188r","article-title":"Proteome analysis of a hepatocyte-specific BIRC5 (survivin)-knockout mouse model during liver regeneration","volume":"13","author":"Bracht","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0660","article-title":"Oral lichen planus and epithelial dysplasia with lichenoid features: a review and discussion with special reference to diagnosis","author":"Sanketh","year":"2016","journal-title":"J Investig Clin Dent"},{"key":"10.1016\/j.autrev.2017.05.016_bb0665","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/00016357.2016.1250944","article-title":"Medical treatments for pregnant patients with oral lichen planus","volume":"75","author":"Wei","year":"2017","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.autrev.2017.05.016_bb0670","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6026\/97320630004248","article-title":"LCK, survivin and PI-3K in the molecular biomarker profiling of oral lichen planus and oral squamous cell carcinoma","volume":"4","author":"Oluwadara","year":"2009","journal-title":"Bioinformation"},{"key":"10.1016\/j.autrev.2017.05.016_bb0675","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/0973-029X.185912","article-title":"Survivin expression in oral lichen planus: role in malignant transformation","volume":"20","author":"Suganya","year":"2016","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0680","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0394632015592101","article-title":"Active inflammatory biomarkers in oral lichen planus","volume":"28","author":"Santarelli","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0685","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-017-9411-6","article-title":"Vitamin D and its role in psoriasis: an overview of the dermatologist and nutritionist","author":"Barrea","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.autrev.2017.05.016_bb0690","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13555-016-0167-9","article-title":"Psoriasis and atopic dermatitis","volume":"7","author":"Griffiths","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.autrev.2017.05.016_bb0695","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000372-200406000-00001","article-title":"Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias","volume":"26","author":"Bowen","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0700","doi-asserted-by":"crossref","first-page":"257059","DOI":"10.5402\/2012\/257059","article-title":"Expression of nuclear factor kappa B and survivin in psoriasis","volume":"2012","author":"Gunduz","year":"2012","journal-title":"ISRN Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0705","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1684\/ejd.2015.2698","article-title":"Enhancement of mRNA expression of survivin and human beta-defensin-3 in lesions of psoriasis vulgaris","volume":"26","author":"Wang","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0710","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/jid.2009.173","article-title":"Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin","volume":"129","author":"Gudjonsson","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0715","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/exd.12111","article-title":"E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro","volume":"22","author":"Dallaglio","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0720","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1684\/ejd.2011.1496","article-title":"Effect of narrow band ultraviolet B on survivin in psoriatic skin lesions","volume":"21","author":"Nagui","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0725","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jdv.12345","article-title":"Cyclooxygenase 2 expression and apoptosis in normal and psoriatic epidermis models exposed to salt water soaks and narrowband ultraviolet B radiation","volume":"29","author":"Gambichler","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0730","first-page":"5964","article-title":"Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients","volume":"61","author":"Andersen","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0735","first-page":"2683","article-title":"Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis","volume":"9","author":"Blanc-Brude","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0740","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/ijc.11634","article-title":"HLA-B35-restricted immune responses against survivin in cancer patients","volume":"108","author":"Reker","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.autrev.2017.05.016_bb0745","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00262-016-1890-x","article-title":"Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma","volume":"65","author":"Fenstermaker","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.autrev.2017.05.016_bb0750","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.vaccine.2004.08.007","article-title":"Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin","volume":"23","author":"Otto","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2017.05.016_bb0755","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/sji.12456","article-title":"Therapeutic vaccination against a modified minimal survivin epitope induces functional CD4 T cells that recognize survivin-expressing cells","volume":"84","author":"Nitschke","year":"2016","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0760","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00262-012-1242-4","article-title":"Metastatic melanoma patients treated with dendritic cell vaccination, interleukin-2 and metronomic cyclophosphamide: results from a phase II trial","volume":"61","author":"Ellebaek","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.autrev.2017.05.016_bb0765","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4049\/jimmunol.174.5.3087","article-title":"Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation","volume":"174","author":"Schaft","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0770","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1026529","article-title":"Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients","volume":"4","author":"Berinstein","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.autrev.2017.05.016_bb0775","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.05.016_bb0780","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/annonc\/mdt249","article-title":"A phase I\/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer","volume":"24","author":"Kelly","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0785","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbrc.2012.07.103","article-title":"Sepantronium bromide (YM155) induces disruption of the ILF3\/p54(nrb) complex, which is required for survivin expression","volume":"425","author":"Yamauchi","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2017.05.016_bb0790","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/1471-2407-12-619","article-title":"Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells","volume":"12","author":"Tao","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.autrev.2017.05.016_bb0795","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00280-012-1868-0","article-title":"The \u201csurvivin suppressants\u201d NSC 80467 and YM155 induce a DNA damage response","volume":"70","author":"Glaros","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0800","first-page":"202","article-title":"Survivin and YM155: how faithful is the liaison?","volume":"2014","author":"Rauch","year":"1845","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2017.05.016_bb0805","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1002\/cncr.26510","article-title":"A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma","volume":"118","author":"Cheson","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.autrev.2017.05.016_bb0810","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.leukres.2013.05.010","article-title":"Combination of YM155, a survivin suppressant with a STAT3 inhibitor: a new strategy to treat diffuse large B-cell lymphoma","volume":"37","author":"Kaneko","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0815","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/annonc\/mdr353","article-title":"A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer","volume":"23","author":"Tolcher","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0820","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPH.0b013e3182a8f58f","volume":"36","author":"Raetz","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0825","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2013.10.039","article-title":"A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel\/prednisone in patients with castration-resistant prostate cancer","volume":"65","author":"Wiechno","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0830","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.autrev.2017.05.016_bb0835","author":"NCT01398462"},{"key":"10.1016\/j.autrev.2017.05.016_bb0840","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10637-014-0198-y","article-title":"Phase I study of the novel Cdc2\/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias","volume":"33","author":"Tibes","year":"2015","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.autrev.2017.05.016_bb0845","doi-asserted-by":"crossref","first-page":"L523","DOI":"10.1152\/ajplung.00129.2014","article-title":"Macitentan reverses early obstructive pulmonary vasculopathy in rats: early intervention in overcoming the survivin-mediated resistance to apoptosis","volume":"308","author":"Shinohara","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0850","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00011-006-5067-5","article-title":"Taurine chloramine inhibits proliferation of rheumatoid arthritis synoviocytes by triggering a p53-dependent pathway","volume":"55","author":"Kontny","year":"2006","journal-title":"Inflamm Res"},{"key":"10.1016\/j.autrev.2017.05.016_bb0855","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","article-title":"Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?","volume":"1171","author":"Aggarwal","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2017.05.016_bb0860","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.autrev.2017.05.016_bb0865","article-title":"STAT3 inhibitors for cancer therapy: have all roads been explored?","volume":"2","author":"Fagard","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.autrev.2017.05.016_bb0870","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/annrheumdis-2011-200968","article-title":"A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease","volume":"71","author":"Pratt","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.016_bb0875","doi-asserted-by":"crossref","first-page":"H1798","DOI":"10.1152\/ajpheart.00654.2011","article-title":"Dehydroepiandrosterone inhibits the Src\/STAT3 constitutive activation in pulmonary arterial hypertension","volume":"301","author":"Paulin","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0880","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases","volume":"12","author":"Schwartz","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0885","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2002-07-2130","article-title":"Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma","volume":"101","author":"Aoki","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.05.016_bb0890","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-210457","article-title":"Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5years: integrated analysis of data from the global clinical trials","author":"Cohen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.016_bb0895","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","article-title":"Janus kinase inhibitors in dermatology: a systematic review","volume":"76","author":"Shreberk-Hassidim","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2017.05.016_bb0900","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.autrev.2017.05.016_bb0905","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2015.03.025","article-title":"IL-6 blockade reverses the abnormal STAT activation of peripheral blood leukocytes from rheumatoid arthritis patients","volume":"158","author":"Ortiz","year":"2015","journal-title":"Clin Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T06:43:23Z","timestamp":1657781003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":181,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1568997217301404"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727675751.793572562","asserted-by":"object"}]},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survivin in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}